CJC 1295 Peptide Experiment: Adverse Effects and Results Bryan Johnson posted on the topic LinkedIn Some peptides can be risky if someone has active or recent cancer. Peptides that raise growth hormone or IGF 1, like IGF 1 LR3, IGF 1 DES, Tesamorelin, Sermorelin, CJC 1295, and Ipamorelin, increase growth signals What are the considerations and potential risks for using Ipamorelin (growth hormone secretagogue) in women, particularly those with a history of cancer, diabetes, or other underlying medical conditions? What Is CJC 1295 Hormone Release? Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org Why You Should Cycle CJC 1295 and Tesamorelin: The 6090 Day Protocol Revolution Health & Wellness